Australian-New Zealand Clinical Trial: Preemptive analgesic role of different doses of oral pregabalin in patients undergoing laparoscopic cholecystectomy

Australia, Oct. 16 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Preemptive analgesic role of different doses of oral pregabalin in patients undergoing laparoscopic cholecystectomy’. The following are the other relevant details related to the trial:

Trial ID: 391843

Submit Date: 5/14/26 6:52

Study Type: Interventional

Intervention: Arm 1 (Intervention): Participants will receive a single oral dose of pregabalin 300 mg with a sip of water 1 hour before induction of general anaesthesia for elective laparoscopic cholecystectomy. All patients will receive the same standardized anaesthetic technique and postoperative analgesic protocol. Intraoperative fentanyl administration...